A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort

American Journal of Human Genetics

Volumn 64, Issue 3, 1999, Pages 808-816

  Hampe, Jochen ^a   Schreiber, Stefan ^a   Shaw, Sarah H ^f   Lau, Kit F ^f   Bridger, Stephen ^c   Macpherson, Andrew J S ^c   Cardon, Lon R ^f   Sakul, Hakan ^f   Harris, Timothy J R ^f   Buckler, Alan ^f   Hall, Jeff ^f   Stokkers, Pieter ^g   Van Deventer, Sander J H ^g   Nürnberg, Peter ^b   Mirza, Mudassar M ^d   Lee, John C W ^e   Lennard Jones, John E ^e   Mathew, Chris G ^e   Curran, Mark E ^f  

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e ST MARK S HOSPITAL   (United Kingdom)

^f Axys Pharmaceuticals Inc   (United States)

^g Axys Pharmaceuticals Inc ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 16; CHROMOSOME 22; CHROMOSOME 4; CHROMOSOME 6P; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TURNER SYNDROME; ULCERATIVE COLITIS; X CHROMOSOME;

EID: 0033358425     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302294     Document Type: Article

References (69)

1. Arulanantham K, Kramer MS, Gryboski JD (1980) The association of inflammatory bowel disease and X chromosomal abnormality. Pediatrics 66:63-67
2. Baeuerle PA (1998) Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr Biol 8:R19-22
3. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM (1998) Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 95:9979-9984
4. Biemond I, Burnham WR, D'Amaro J, Langman MJ (1986) HLA-A and -B antigens in inflammatory bowel disease. Gut 27: 934-941
5. Bouma G, Oudkerk Pool M, Crusius JB, Schreuder GM, Hellemans HP, Meijer BU, Kostense PJ, et al. (1997) Evidence for genetic heterogeneity in inflammatory bowel disease (IBD): HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol 109:175-179
6. Bouma G, Poen AC, Garcia-Gonzalez MA, Schreuder GMT, Felt-Bersma RJF, Meuwissen SGM, Pena AS (1998) HLA-DRB1 * 03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 47:451-455
7. Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545-568
8. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q; evidence for epistasis between 1p and IBD1. PNAS 95:7502-7507
9. Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, et al (1996) Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111:604-607
10. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJS, Cardon LR, et al. (1998) genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 115:1066-1071
11. Delpre G, Kadish U, Gazit E, Joshua H, Zamir R (1980) HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology 78:1452-1457
12. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, Chensny LJ, Brown JL, et al. (1998) Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 63:95-100
13. Fielding JF (1986) The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J Clin Gastroenterol 8:655-657
14. Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S (1996) An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3 * 0301 allele. Proc Natl Acad Sci USA 93:5094-5098
15. Fujita K, Naito S, Okabe N, Yao T (1984) Immunological studies in Crohn's disease I: association with HLA systems in the Japanese. J Clin Lab Immunol 14:99-102
16. Gahmberg CG, Valmu L, Fagerholm S, Kotovuori P, Ihanus E, Tian L, Pessa-Morikawa T (1998) Leukocyte integrins and inflammation. Cell Mol Life Sci 54:549-555
17. Gleeson MH, Walker JS, Wentzel J, Chapman JA, Harris R (1972) Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut 13:438-440
18. Hall J, Nanthakumar E (1997) Automated flourescent genotyping. In: Boyle AL (ed) Current protocols in human genetics. Vol 2. John Wiley & Sons, pp 2.8.1-2.8.19
19. Hamilton SR (1987) The differential diagnosis of idiopathic inflammatory disease by colorectal biopsy. Int J Colorectal Dis 2:113-117
20. Hampe J, Hermann B, Bridger S, MacPherson AJS, Mathew CG, Schreiber S (1999) The interferon gamma gene as a positional and functional candidate gene for inflammatory bowel disease. Intl J Colorectal Dis 13:260-263
21. Hampe J, Wienker T, Nurnberg P, Schreiber S. Mapping genes for inflammatory bowel disease: implications of study design and population structure. Hum Hered (in press)
22. Hayward PA, Satsangi J, Jewell DP (1996) Inflammatory bowel disease and the X chromosome. Qjm 89:713-718
23. Hochstrasser M (1996) Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405-439
24. Hugot JP, Laurent Puig P, Gower Rousseau C, Caillat Zucman S, Beaugerie L, Dupas JL, Van Gossum A, et al. (1994) Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. Am J Med Genet 52:207-213
25. Hugor JP, Laurentpuig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379:821-823
26. Idury RM, Cardon LR (1997) A simple method for automated allele binning in microsatellite markers. Genome Res 7: 1104-1109
27. Knudtzon J, Ledaal P, Middelthon-Moe M, Aarskog D (1988) 45,X/47,XY,+13 mosaicism and Crohn's disease, Acta Paediatr Scand 77:922-924
28. Knudtzon J, Svane S (1988) Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand 223:375-378
29. Kohler JA, Grant DB (1981) Crohn's disease in Turner's syndrome. Br Med J (Clin Res Ed) 282:950
30. Koutroubakis I, Manousos ON, Meuwissen SG, Pena AS (1996) Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43:381-393
31. Kruglyak L, Daly MJ, Lander ES (1995) Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 57:439-454
32. Kruglyak L, Lander ES (1996) Limits on fine mapping of complex traits. Am J Hum Genet 58:1092-1093
33. Kuster W, Pascoe L, Purrmann J, Funk S, Majewski F (1989) The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet 32:105-108
34. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6
35. Matise TC, Perlin M, Chakravarti A (1994) Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet 6: 384-390
36. Mayberry JF (1989) Recent epidemiology of ulcerative colitis and Crohn's disease. Int J Colorectal Dis 4:59-66
37. Mirza MM, Lee J, Teare D, Hugot JP, Laurent-Puig P, Colombel JF, Hodgson SV, et al. (1998) Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet 35: 218-221
38. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A (1995) HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467
39. Naom I, Lee J, Ford D, Bowman SJ, Lanchbury JS, Haris I, Hodgson SV, et al. (1996) Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet 59:226-233
40. Nordgren S, Fasth S, Hulten L (1992) Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment. Int J Colorectal Dis 7:214-218
41. Ohmen JD, Yang HY, Yamamoto KK, Zhao HY, Ma Y, Bentley LG, Huang Z, et al. (1996) Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerarive colitis. Hum Mol Genet 5:1679-1683
42. Orholm M, Iselius L, Sorensen TI, Munkholm P, Langholz E, Binder V, Orholm M, et al. (1993) Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ 306:20-24
43. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V (1991) Familial occurrence of inflammatory bowel disease. N Engl J Med 324:84-88
44. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeerts P (1996) Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111:597-603
45. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, et al. (1998) HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 30:56-61
46. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H (1996) Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110:1053-1060
47. Podolsky DK (1991) Inflammatory bowel disease. N Engl J Med 325:928-937
48. Price WH (1979) A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome. J Med Genet 16:263-266
49. Probert CS, Jayanthi V, Rampton DS, Mayberry JF (1996) Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and actiological clues. Int J Colorectal Dis 11:25-28
50. Purrmann J, Korsten S, Bertrams J, Miller B, Lapsien B, Munch H, Reis HE, et al. (1985) HLA haplotype study in familial Crohn disease. Z Gastroenterol 23:432-437
51. Risch N (1990) Linkage strategies for genetically complex traits II: the power of affected relative pairs. Am J Hum Genet 46:229-241
52. Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382-389
53. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI (1989) Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 96:1016-1020
54. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, et al. (1997) Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112:1845-1853
55. Russell AS, Percy JS, Schlaut J, Sartor VE, Goodhart JM, Sherbaniuk RW, Kidd EG (1975) Transplantation antigens in Crohn's disease: linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis 20:359-361
56. Satsangi J, Grootscholten C, Holt H, Jewell DP (1996a) Clinical patterns of familial inflammatory bowel disease. Gut 38:738-741
57. Sutsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, et al. (1996b) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199-202
58. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP (1996c) Contribution of genes of the major histocompanbility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217
59. Scarpa R, Lubrano E, Castiglione F, Morace F, Ames PR, Oriente P (1996) Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. Clin Exp Rheumatol 14:449-450
60. Schmid P, Itin P, Cherry G, Bi C, Cox DA (1998) Enhanced expression of transforming growth factor-β type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 152:485-493
61. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A (1995) Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108:21-33
62. Shivananda S, Lennard Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690-697
63. Smolen JS, Gangl A, Polterauer P, Menzel EJ, Mayr WR (1982) HLA antigens in inflammatory bowel disease. Gastroenterology 82:34-38
64. Suarez BK, Hampe CL, Van Eerdewegh PD (1994) Problems in replicating linkage claims in psychaitry. In: Gershon ES, Cloninger CR (eds) Genetic approaches to mental disorders. American Psychiatric Press, Washington DC, pp 23-46
65. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ (1996) Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312:95-96
66. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, et al. (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104:741-748
67. Tysk C, Lindberg E, Jarnerot G, Floderus Myrhed B (1988) Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29:990-996
68. Uyar FA, Imeryuz N, Saruhan-Direskeneli G, Ceken H, Ozdogan O, Sahin S, Tozun N (1998) The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet 25:293-296
69. van den Berg Loonen EM, Dekker Saeys BJ, Meuwissen SG, Nijenhuis LE, Engelfriet CP (1977) Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet 4: 167-175